Also published in reuters.com:
Panel clears audit firms of Olympus scandal blame
x hide permanently

Valeant Names ValueAct's Ubben to Board effective Oct. 1

reuters.com

Sept 25 (Reuters) - Valeant Pharmaceuticals International Inc said on Thursday it had named the head of a top shareholder, ValueAct Capital, to its board of directors and vowed to continue with its hostile takeover attempt on Botox maker Allergan Inc...

Mentions: Management hostile takeover Shareholders